tiprankstipranks
Trending News
More News >
Adhera Therapeutics (ATRX)
OTHER OTC:ATRX
US Market

Adhera Therapeutics (ATRX) Ratios

Compare
13 Followers

Adhera Therapeutics Ratios

ATRX's free cash flow for Q3 2023 was $0.00. For the 2023 fiscal year, ATRX's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 22Dec 21Dec 20Dec 19
Liquidity Ratios
Current Ratio
<0.01 <0.01 <0.01 <0.01 0.04
Quick Ratio
<0.01 <0.01 <0.01 <0.01 0.04
Cash Ratio
<0.01 <0.01 <0.01 <0.01 <0.01
Solvency Ratio
-0.02 -0.02 -0.22 -0.25 -1.15
Operating Cash Flow Ratio
-0.06 -0.06 -0.03 -0.04 -0.85
Short-Term Operating Cash Flow Coverage
-0.16 -0.16 -0.10 -0.09 -1.64
Net Current Asset Value
$ -22.19M$ -22.19M$ -25.11M$ -14.77M$ -9.89M
Leverage Ratios
Debt-to-Assets Ratio
108.67 108.67 33.99 6.32K 12.69
Debt-to-Equity Ratio
-0.39 -0.39 -0.27 -0.43 -0.54
Debt-to-Capital Ratio
-0.63 -0.63 -0.36 -0.75 -1.17
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
>-0.01 >-0.01 >-0.01 >-0.01 -0.04
Debt Service Coverage Ratio
0.00 0.00 0.00 -0.25 -1.87
Interest Coverage Ratio
-0.51 -0.51 -0.47 -1.15 -17.09
Debt to Market Cap
11.89K 4.54 0.02 0.03 0.02
Interest Debt Per Share
5.09 5.09 12.45 14.88 11.05
Net Debt to EBITDA
0.00 0.00 0.00 -3.17 -0.47
Profitability Margins
Gross Profit Margin
0.00%0.00%0.00%0.00%-62.30%
EBIT Margin
0.00%0.00%0.00%0.00%-4490.48%
EBITDA Margin
0.00%0.00%0.00%0.00%-4457.94%
Operating Profit Margin
0.00%0.00%0.00%0.00%-4490.48%
Pretax Profit Margin
0.00%0.00%0.00%0.00%-4753.17%
Net Profit Margin
0.00%0.00%0.00%0.00%-4753.17%
Continuous Operations Profit Margin
0.00%0.00%0.00%0.00%-4753.17%
Net Income Per EBT
100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT
130.66%130.66%942.28%184.88%105.85%
Return on Assets (ROA)
-2675.95%-2675.95%-3240.31%-376600.00%-2851.90%
Return on Equity (ROE)
8.94%9.53%25.30%25.49%121.15%
Return on Capital Employed (ROCE)
7.29%7.29%2.68%13.79%114.45%
Return on Invested Capital (ROIC)
11.90%11.90%3.65%24.09%248.32%
Return on Tangible Assets
-2675.95%-2675.95%-3240.31%-376600.00%-2851.90%
Earnings Yield
-915944.54%-111.71%-1.74%-2.09%-4.60%
Efficiency Ratios
Receivables Turnover
0.00 0.00 0.00 0.00 0.00
Payables Turnover
0.00 0.00 0.00 0.00 0.29
Inventory Turnover
0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.00 0.00 0.00 0.00 0.00
Asset Turnover
0.00 0.00 0.00 0.00 0.60
Working Capital Turnover Ratio
0.00 0.00 0.00 0.00 -0.07
Cash Conversion Cycle
0.00 0.00 0.00 0.00 -1.25K
Days of Sales Outstanding
0.00 0.00 0.00 0.00 0.00
Days of Inventory Outstanding
0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
0.00 0.00 0.00 0.00 1.25K
Operating Cycle
0.00 0.00 0.00 0.00 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
-0.61 -0.61 -1.02 -1.08 -16.12
Free Cash Flow Per Share
-0.61 -0.61 -1.02 -1.08 -16.12
CapEx Per Share
0.00 0.00 0.00 0.00 0.00
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
0.00 0.00 -0.32 -0.38 -5.81
Capital Expenditure Coverage Ratio
0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Coverage Ratio
-0.16 -0.16 -0.10 -0.09 -1.64
Operating Cash Flow to Sales Ratio
0.00 0.00 0.00 0.00 -34.67
Free Cash Flow Yield
-195983.38%-74.77%-0.18%-0.33%-3.36%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
>-0.01 -0.90 -57.33 -47.94 -21.72
Price-to-Sales (P/S) Ratio
0.00 0.00 0.00 0.00 1.03K
Price-to-Book (P/B) Ratio
>-0.01 -0.09 -14.50 -12.22 -26.32
Price-to-Free Cash Flow (P/FCF) Ratio
>-0.01 -1.34 -547.52 -307.06 -29.78
Price-to-Operating Cash Flow Ratio
>-0.01 -1.34 -547.52 -307.06 -29.78
Price-to-Earnings Growth (PEG) Ratio
>-0.01 <0.01 -1.85 0.79 0.89
Price-to-Fair Value
>-0.01 -0.09 -14.50 -12.22 -26.32
Enterprise Value Multiple
0.00 0.00 0.00 -93.81 -23.63
Enterprise Value
8.55M 10.45M 370.69M 186.87M 265.46M
EV to EBITDA
0.00 0.00 0.00 -93.81 -23.63
EV to Sales
0.00 0.00 0.00 0.00 1.05K
EV to Free Cash Flow
-6.05 -7.38 -557.43 -317.80 -30.38
EV to Operating Cash Flow
-6.05 -7.38 -557.43 -317.80 -30.38
Tangible Book Value Per Share
-9.61 -9.61 -38.61 -27.16 -18.24
Shareholders’ Equity Per Share
-9.61 -9.61 -38.61 -27.16 -18.24
Tax and Other Ratios
Effective Tax Rate
0.00 0.00 0.00 0.00 0.00
Revenue Per Share
0.00 0.00 0.00 0.00 0.46
Net Income Per Share
-0.92 -0.92 -9.77 -6.93 -22.10
Tax Burden
1.00 1.00 1.00 1.00 1.00
Interest Burden
1.31 1.31 9.42 1.89 1.06
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.00 0.00 0.00 0.00 18.70
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 3.04
Income Quality
0.67 0.67 0.10 0.16 0.73
Currency in USD